絞り込み

16636

広告

新種の光るクモヒトデ発見…中部大チーム、海底洞窟で (読売新聞)

オーストラリアのクリスマス島の海底洞窟で、新種の光るクモヒトデを発見したと、中部大の大場裕一教授(発光生物学)らの研究チームが発表した。シンガポールの学術誌に論...

  1. 眠れる鉱物標本、最新技術で脚光 京大「比...
  2. [企業] テレビ広告に薬価を表示させるの...
  3. [企業] Lilly 馴染みのInnov...
  4. ロシアの船舶型原発、北部の港で稼働へ 輸...

ニュース一覧

miR-384-5p targets Gli2 and negatively regulates age-related osteogenic differentiation of rat bone marrow mesenchymal stem cells.

著者 Li X , Wu J , Liu S , Zhang K , Miao X , Li J , Shi Z , Gao Y
Stem Cells Dev.2019 Apr 05 ; ():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (27view , 0users)

Full Text Sources

Aberrant microRNA (miRNA) expression correlates with age-related osteoporosis, which impairs bone formation by regulating osteoblastic activity, thus leading to age-related bone loss. In this study, we observed that miR-384-5p was significantly upregulated in bone marrow mesenchymal stem cells (BMSCs) from aged rats as compared with BMSCs from young rats. In vitro functional assays revealed that overexpression of miR-384-5p in young BMSCs inhibited osteogenic differentiation and accelerated senescence, whereas a knockdown of miR-384-5p in aged BMSCs had the opposite effects. Furthermore, we demonstrated that miR-384-5p inhibited the expression of Gli2 both at the mRNA and protein levels by directly binding to the 3' untranslated region (3'UTR) of Gli2 mRNA. The osteogenic capacity of Gli2 knockdown BMSCs was rejuvenated by miR-384-5p inhibition. Finally, in vivo assays showed that inhibition of miR-384-5p prevented bone loss and increased the osteogenic capacity in aged rats. Overall, our study suggests that miR-384-5p functions as a negative regulator of osteogenesis, indicating that inhibition of miR-384-5p may be a therapeutic strategy against age-related bone loss.
PMID: 30950325 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード